Dynavax to Present at the Cowen and Company 35th Annual Health Care Conference
(firmenpresse) - BERKELEY, CA -- (Marketwired) -- 02/27/15 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that Eddie Gray, the Company's Chief Executive Officer, will present at the Cowen and Company 35th Annual Health Care Conference on Monday, March 2, 2015 at 1:30 PM Eastern Time at the Boston Marriott Copley Place Hotel in Boston.
A live webcast of the presentation will be available by visiting the "Investors" section of the Dynavax website or may be reached directly at:
Dynavax, a clinical-stage biopharmaceutical company, uses TLR biology to discover and develop novel vaccines and therapeutics in the areas of infectious and inflammatory diseases and oncology. Dynavax's lead product candidate is HEPLISAV-B, a Phase 3 investigational adult hepatitis B vaccine. For more information visit .
Michael Ostrach
Chief Financial Officer
510-665-7257
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 27.02.2015 - 21:59 Uhr
Sprache: Deutsch
News-ID 374988
Anzahl Zeichen: 0
contact information:
Town:
BERKELEY, CA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 256 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Dynavax to Present at the Cowen and Company 35th Annual Health Care Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Dynavax Technologies (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
